Atrium Therapeutics, Inc.
RNA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0002093101
No open-market purchases or sales by Atrium Therapeutics, Inc. insiders were filed in the last 90 days; 154 institutions reported holding it in 13F filings for Q2 2026, worth $192.8M in total; no superinvestor holds it.
Q1 2026 vs. Q4 2025
How the institutions holding Atrium Therapeutics, Inc. changed between Q4 2025 and Q1 2026.
All holders in Q1 2026All holders in Q4 2025
| Measure | Q4 2025 | Q1 2026 | Change |
|---|---|---|---|
| Holders | 0 | 163 | +163 |
| Shares | 0 | 14.8M | +14.8M |
| Value | $0 | $198.3M | +$198.3M |
New holders (163)
Institutions that held Atrium Therapeutics, Inc. at the end of Q1 2026 but not at the end of Q4 2025.
Showing the largest 100 of 163 by value.
Sold out (0)
Institutions that held Atrium Therapeutics, Inc. at the end of Q4 2025 and filed for Q1 2026 without it.
None.